- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
This Week in Aesthetics: November 1-5
This week in aesthetics, we highlight the most recent “Pointers With Dr Portela”, nutraceuticals for female hair growth, and more.
This week in aesthetics, Galderma, Sofregen enter an agreement to develop silk-based biostimulators, a survey details what digital resources patients use when researching health care, Dustin Portela, DO, honors the end of Eczema Awareness Month with a video explaining the skin condition, and Glynis Ablon, MD, FAAD, discusses her research on nutraceuticals for hair growth in midlife.
Galderma, Sofregen Enter Agreement to Develop Silk-based Biostimulators
Galderma and Sofregen Medical announced they have entered into an agreement to co-develop a novel line of silk-based biostimulators that will enable immediate volume restoration and provide structure for new tissue generation.
Survey: Patients lean on digital resources when researching health care
Most respondents look online when finding a physician or other care entity.
Pointers With Dr Portela: The 5 Types of Eczema
In this week’s Pointers with Dr Portela, the 208SkinDoc honors the end of Eczema Awareness Month with a video explaining the skin condition.
Nutraceuticals Show Promise for Female Hair Growth
Glynis Ablon, MD, FAAD, discusses her research on nutraceuticals for hair growth in midlife.
